a public good project by the
Synthesis
Company
of California

© 2026

R. Kirk McPherson | doi.page

0 works0 citations0 h-index

R. Kirk McPherson

American Dental Education Association(US)John Wiley & Sons (United States)(US)

Publications by Year

Research Areas

Glycogen Storage Diseases and Myoclonus, Diabetes Treatment and Management, Pancreatic function and diabetes, Carbohydrate Chemistry and Synthesis, Metabolism, Diabetes, and Cancer

Most-Cited Works

→ Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo(1998)231 cited
→ Human liver glycogen phosphorylase inhibitors bind at a new allosteric site(2000)126 cited
→ Transgenic mice expressing the human GLUT4/muscle-fat facilitative glucose transporter protein exhibit efficient glycemic control.(1993)104 cited
→ Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene.(1994)103 cited
→ Indole-2-carboxamide Inhibitors of Human Liver Glycogen Phosphorylase(1998)102 cited
→ Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1(2011)102 cited
→

Actions of Novel Antidiabetic Agent Englitazone in Hyperglycemic Hyperinsulinemic ob/ob Mice

(1990)

97 cited

→ Anilinoquinazoline Inhibitors of Fructose 1,6-Bisphosphatase Bind at a Novel Allosteric Site: Synthesis, In Vitro Characterization, and X-ray Crystallography(2002)82 cited

→ Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes.(2000)64 cited

→ Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2(2009)58 cited